The DOI matches its Crossref record; 217 of the 217 references it cites were found in a registry or an index.
Phage display screening of therapeutic peptide for cancer targeting and therapy
Open accessAbstract
Recently, phage display technology has been announced as the recipient of Nobel Prize in Chemistry 2018. Phage display technique allows high affinity target-binding peptides to be selected from a complex mixture pool of billions of displayed peptides on phage in a combinatorial library and could be further enriched through the biopanning process; proving to be a powerful technique in the screening of peptide with high affinity and selectivity. In this review, we will first discuss the modifications in phage display techniques used to isolate various cancer-specific ligands by in situ,in vitro,in vivo, and ex vivo screening methods. We will then discuss prominent examples of solid tumor targeting-peptides; namely peptide targeting tumor vasculature, tumor microenvironment (TME) and over-expressed receptors on cancer cells identified through phage display screening. We will also discuss the current challenges and future outlook for targeting peptide-based therapeutics in the clinics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Tumeh, P. C., Harview, C. L., Yearley, J. H., Shintaku, I. P., Taylor, E. J. M., Robert, L., Chmielowski, B., Spasic, M., Henry, G., Ciobanu, V., et al. (2014) · Nature · doi:10.1038/nature13954 · Cited by 6,609
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Smith, G. P. (1985) · Science · doi:10.1126/science.4001944 · Cited by 4,143
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Identification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., & Heeschen, C. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.06.002 · Cited by 2,897
Prospective Identification of Tumorigenic Prostate Cancer Stem Cells
Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J., & Maitland, N. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2018 · Cited by 2,820
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Sallusto, F., Cella, M., Danieli, C., & Lanzavecchia, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.389 · Cited by 2,500
Olayioye, M. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3159 · Cited by 2,434
Zou, W., Wolchok, J. D., & Chen, L. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7118 · Cited by 2,400
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product
Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M.-L., Kmiecik, T. E., Vande Woude, G. F., & Aaronson, S. A. (1991) · Science · doi:10.1126/science.1846706 · Cited by 2,236
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
Endothelial/Pericyte Interactions
Armulik, A., Abramsson, A., & Betsholtz, C. (2005) · Circulation Research · doi:10.1161/01.res.0000182903.16652.d7 · Cited by 2,048
Vascular Endothelial Growth Factor and Angiogenesis
Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., & De Bruijn, E. A. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.3 · Cited by 1,824
AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor Cells
Yin, A. H., Miraglia, S., Zanjani, E. D., Almeida-Porada, G., Ogawa, M., Leary, A. G., Olweus, J., Kearney, J., & Buck, D. W. (1997) · Blood · doi:10.1182/blood.v90.12.5002 · Cited by 1,822
Cancerous stem cells can arise from pediatric brain tumors
Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M., Geschwind, D. H., Bronner-Fraser, M., & Kornblum, H. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036535100 · Cited by 1,817
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Yu, H., Kortylewski, M., & Pardoll, D. (2007) · Nature Reviews Immunology · doi:10.1038/nri1995 · Cited by 1,804
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Boehm, T., Folkman, J., Browder, T., & O'Reilly, M. S. (1997) · Nature · doi:10.1038/37126 · Cited by 1,683
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
Cho, H.-S., Mason, K., Ramyar, K. X., Stanley, A. M., Gabelli, S. B., Denney, D. W., & Leahy, D. J. (2003) · Nature · doi:10.1038/nature01392 · Cited by 1,612
Brooks, P. C., Strömblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., & Cheresh, D. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81235-0 · Cited by 1,552
Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer
Mendelsohn, J., & Baselga, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.504 · Cited by 1,255
Su, S., Chen, J., Yao, H., Liu, J., Yu, S., Lao, L., Wang, M., Luo, M., Xing, Y., Chen, F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.01.009 · Cited by 1,230
Self-citationOrgan targeting In vivo using phage display peptide libraries
Pasqualini, R., & Ruoslahti, E. (1996) · Nature · doi:10.1038/380364a0 · Cited by 1,221
Low, P. S., Henne, W. A., & Doorneweerd, D. D. (2008) · Accounts of Chemical Research · doi:10.1021/ar7000815 · Cited by 1,173
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
Baselga, J., & Swain, S. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2656 · Cited by 1,142
Proteolytic remodeling of extracellular matrix
Birkedal-Hansen, H. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80116-2 · Cited by 1,074
Endothelial-pericyte interactions in angiogenesis
Gerhardt, H., & Betsholtz, C. (2003) · Cell and Tissue Research · doi:10.1007/s00441-003-0745-x · Cited by 1,057
A peptide carrier for the delivery of biologically active proteins into mammalian cells
Morris, M. C., Depollier, J., Mery, J., Heitz, F., & Divita, G. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1173 · Cited by 1,018
Clinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004
Molecular cloning of a new transforming gene from a chemically transformed human cell line
Cooper, C. S., Park, M., Blair, D. G., Tainsky, M. A., Huebner, K., Croce, C. M., & Vande Woude, G. F. (1984) · Nature · doi:10.1038/311029a0 · Cited by 989
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
Bergers, G., Javaherian, K., Lo, K.-M., Folkman, J., & Hanahan, D. (1999) · Science · doi:10.1126/science.284.5415.808 · Cited by 988
Miraglia, S., Godfrey, W., Yin, A. H., Atkins, K., Warnke, R., Holden, J. T., Bray, R. A., Waller, E. K., & Buck, D. W. (1997) · Blood · doi:10.1182/blood.v90.12.5013 · Cited by 984
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 966
Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3090 · Cited by 940
Targeting the EGFR signaling pathway in cancer therapy
Seshacharyulu, P., Ponnusamy, M. P., Haridas, D., Jain, M., Ganti, A. K., & Batra, S. K. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.648617 · Cited by 913
Ross, J. F., Chaudhuri, P. K., & Ratnam, M. (1994) · Cancer · doi:10.1002/1097-0142(19940501)73:9<2432::aid-cncr2820730929>3.0.co;2-s · Cited by 891
Wells, A. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00015-1 · Cited by 817
Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., & Takeyama, H. (2015) · Cancers · doi:10.3390/cancers7040902 · Cited by 774
Delivery of molecular and cellular medicine to solid tumors
Jain, R. K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.011 · Cited by 774
αv Integrins as receptors for tumor targeting by circulating ligands
Pasqualini, R., Koivunen, E., & Ruoslahti, E. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-542 · Cited by 744
Prewett, M. C., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K. D., Overholser, J. C., Hooper, A. T., Pytowski, B., Witte, L., et al. (1999) · PubMed · Cited by 713
Bostwick, D. G., Pacelli, A., Blute, M., Roche, P., & Murphy, G. P. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980601)82:11<2256::aid-cncr22>3.0.co;2-s · Cited by 698
Chen, D. S., Irving, B. A., & Hodi, F. S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1362 · Cited by 654
HER2: Biology, Detection, and Clinical Implications
Gutierrez, C., & Schiff, R. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2010-0454-rar.1 · Cited by 652
Medrek, C., Pontén, F., Jirström, K., & Leandersson, K. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-306 · Cited by 647
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3
Chen, J., Yao, Y., Gong, C., Yu, F., Su, S., Chen, J., Liu, B., Deng, H., Wang, F., Lin, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.006 · Cited by 641
Self-citationA Central Role for HER3 in HER2 -Amplified Breast Cancer: Implications for Targeted Therapy
Lee-Hoeflich, S. T., Crocker, L., Yao, E., Pham, T., Munroe, X., Hoeflich, K. P., Sliwkowski, M. X., & Stern, H. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0380 · Cited by 629
Georgoudaki, A.-M., Prokopec, K. E., Boura, V. F., Hellqvist, E., Sohn, S., Östling, J., Dahan, R., Harris, R. A., Rantalainen, M., Klevebring, D., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.084 · Cited by 609
Steps toward mapping the human vasculature by phage display
Arap, W., Kolonin, M. G., Trepel, M., Lahdenranta, J., Cardó-Vila, M., Giordano, R. J., Mintz, P. J., Ardelt, P. U., Yao, V. J., Vidal, C. I., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-121 · Cited by 607
Sweat, S. D., Pacelli, A., Murphy, G. P., & Bostwick, D. G. (1998) · Urology · doi:10.1016/s0090-4295(98)00278-7 · Cited by 607
HER2 testing in gastric cancer: a practical approach
Rüschoff, J., Hanna, W., Bilous, M., Hofmann, M., Osamura, R. Y., Penault-Llorca, F., van de Vijver, M., & Viale, G. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.198 · Cited by 595
Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues
Wright, G. L., Haley, C., Beckett, M. L., & Schellhammer, P. F. (1995) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/1078-1439(95)00002-y · Cited by 591
Tumor targeting with a selective gelatinase inhibitor
Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O. P., Heikkilä, P., Kantor, C., Gahmberg, C. G., Salo, T., Konttinen, Y. T., et al. (1999) · Nature Biotechnology · doi:10.1038/11703 · Cited by 567
ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization
Kallioniemi, O. P., Kallioniemi, A., Kurisu, W., Thor, A., Chen, L. C., Smith, H. S., Waldman, F. M., Pinkel, D., & Gray, J. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5321 · Cited by 555
Significance of M2-Polarized Tumor-Associated Macrophage in Pancreatic Cancer
Kurahara, H., Shinchi, H., Mataki, Y., Maemura, K., Noma, H., Kubo, F., Sakoda, M., Ueno, S., Natsugoe, S., & Takao, S. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2009.05.026 · Cited by 552
The Distinctive Nature of HER2-Positive Breast Cancers
Burstein, H. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058197 · Cited by 541
Jain, R. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00131-9 · Cited by 529
Evaluation of the use of therapeutic peptides for cancer treatment
Marqus, S., Pirogova, E., & Piva, T. J. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0328-x · Cited by 512
Kelemen, L. E. (2006) · International Journal of Cancer · doi:10.1002/ijc.21712 · Cited by 509
Lehmann, J., Riethmüller, G., & Johnson, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9891 · Cited by 508
In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.
Milas, L., Mason, K. A., Hunter, N. R., et al. (2000) · PubMed · Cited by 503
Activation of fibroblasts in cancer stroma
Räsänen, K., & Vaheri, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.032 · Cited by 499
A tumor-homing peptide with a targeting specificity related to lymphatic vessels
Laakkonen, P., Porkka, K., Hoffman, J. A., & Ruoslahti, E. (2002) · Nature Medicine · doi:10.1038/nm720 · Cited by 498
Cancer Treatment Using Peptides: Current Therapies and Future Prospects
Thundimadathil, J. (2012) · Journal of Amino Acids · doi:10.1155/2012/967347 · Cited by 491
Koivunen, E., Wang, B., & Ruoslahti, E. (1995) · Nature Biotechnology · doi:10.1038/nbt0395-265 · Cited by 477
Expression of the Met/HGF receptor in normal and neoplastic human tissues.
Renzo, M. F. D., Narsimhan, R. P., Olivero, M., Bretti, S., Giordano, S., Médico, E., Gaglia, P., Zara, P., & Comoglio, P. M. (1991) · PubMed · Cited by 474
The ins and outs of fibronectin matrix assembly
Wierzbicka-Patynowski, I., & Schwarzbauer, J. E. (2003) · Journal of Cell Science · doi:10.1242/jcs.00670 · Cited by 473
Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.
Rajotte, D., Arap, W., Hagedorn, M., Koivunen, E., Pasqualini, R., & Ruoslahti, E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3008 · Cited by 457
Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle
Kelly, K. A., Allport, J. R., Tsourkas, A., Shinde-Patil, V. R., Josephson, L., & Weissleder, R. (2005) · Circulation Research · doi:10.1161/01.res.0000155722.17881.dd · Cited by 449
Kerbel, R. S. (1991) · BioEssays · doi:10.1002/bies.950130106 · Cited by 441
Takayama, H., LaRochelle, W. J., Sharp, R., Otsuka, T., Kriebel, P., Anver, M., Aaronson, S. A., & Merlino, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.701 · Cited by 440
Antiangiogenic Activity of the Cleaved Conformation of the Serpin Antithrombin
O'Reilly, M. S., Pirie-Shepherd, S., Lane, W. S., & Folkman, J. (1999) · Science · doi:10.1126/science.285.5435.1926 · Cited by 432
Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment
Augsten, M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00062 · Cited by 427
New insights into the role of extracellular matrix during tumor onset and progression
Pupa, S. M., Ménard, S., Forti, S., & Tagliabue, E. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10142 · Cited by 419
Li, Z., Zhao, R., Wu, X., Sun, Y., Yao, M., Li, J., Xu, Y., & Gu, J. (2005) · The FASEB Journal · doi:10.1096/fj.05-4058com · Cited by 419
Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles
Ruoslahti, E. (2012) · Advanced Materials · doi:10.1002/adma.201200454 · Cited by 419
Targeting STAT3 in cancer: how successful are we?
Yue, P., & Turkson, J. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802565791 · Cited by 413
Cancer associated fibroblasts in cancer pathogenesis
Franco, O. E., Shaw, A. K., Strand, D. W., & Hayward, S. W. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.10.010 · Cited by 394
Rong, S., Segal, S., Anver, M., Resau, J. H., & Vande Woude, G. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4731 · Cited by 363
Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy
Denekamp, J. (1993) · The British Journal of Radiology · doi:10.1259/0007-1285-66-783-181 · Cited by 358
Advancement and applications of peptide phage display technology in biomedical science
Wu, C.-H., Liu, I.-J., Lu, R.-M., & Wu, H.-C. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0223-x · Cited by 339
Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.
Humphrey, P. A., Zhu, X., Zarnegar, R., Swanson, P. E., Ratliff, T. L., Vollmer, R. T., & Day, M. L. (1995) · Europe PMC (PubMed Central) · Cited by 335
Signaling through the epidermal growth factor receptor during the development of malignancy
Grandis, J. R., & Sok, J. C. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.01.002 · Cited by 320
Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival
Cieslewicz, M., Tang, J., Yu, J. L., Cao, H., Zavaljevski, M., Motoyama, K., Lieber, A., Raines, E. W., & Pun, S. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312197110 · Cited by 314
Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas.
Renzo, M. F. D., Olivero, M., Ferro, S., Prat, M., Bongarzone, I., Pilotti, S., Belfiore, A., Costantino, A., Vigneri, R., & Pierotti, M. A. (1992) · PubMed · Cited by 312
HER2 testing in gastric cancer: An update
Abrahao-Machado, L. F., & Scapulatempo-Neto, C. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i19.4619 · Cited by 310
The Use of Therapeutic Peptides to Target and to Kill Cancer Cells
J. Boohaker, R., W. Lee, M., Vishnubhotla, P., M. Perez, J. L., & R. Khaled, A. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712801661004 · Cited by 302
Ioachim, E., Charchanti, A., Briasoulis, E., Karavasilis, V, Tsanou, H., Arvanitis, D. L., Agnantis, N. J., & Pavlidis, N. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00210-1 · Cited by 301
Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3
Saunders, W. B., Bohnsack, B. L., Faske, J. B., Anthis, N. J., Bayless, K. J., Hirschi, K. K., & Davis, G. E. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200603176 · Cited by 296
Smith, L. M., Nesterova, A., Ryan, M. C., Duniho, S., Jonas, M., Anderson, M., Zabinski, R. F., Sutherland, M. K., Gerber, H.-P., Van Orden, K. L., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604437 · Cited by 286
Targeting the prostate for destruction through a vascular address
Arap, W., Haedicke, W., Bernasconi, M., Kain, R., Rajotte, D., Krajewski, S., Ellerby, H. M., Bredesen, D. E., Pasqualini, R., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241655998 · Cited by 285
CD146, a multi-functional molecule beyond adhesion
Wang, Z., & Yan, X. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.11.049 · Cited by 281
Florek, M., Haase, M., Marzesco, A.-M., Freund, D., Ehninger, G., Huttner, W. B., & Corbeil, D. (2005) · Cell and Tissue Research · doi:10.1007/s00441-004-1018-z · Cited by 276
Biopanning and rapid analysis of selective interactive ligands
Giordano, R. J., Cardó‐Vila, M., Lahdenranta, J., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1249 · Cited by 276
Targeting HER2 for the Treatment of Breast Cancer
Rimawi, M. F., Schiff, R., & Osborne, C. K. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-042513-015127 · Cited by 268
Receptor Targeting for Tumor Localisation and Therapy with Radiopeptides
Heppeler, A., Froidevaux, S., Eberle, A., & Maecke, H. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003374516 · Cited by 258
Fibronectin as target for tumor therapy
Kaspar, M., Zardi, L., & Neri, D. (2006) · International Journal of Cancer · doi:10.1002/ijc.21677 · Cited by 249
Cancer stem cell: target for anti‐cancer therapy
Tang, C., Ang, B. T., & Pervaiz, S. (2007) · The FASEB Journal · doi:10.1096/fj.07-8560rev · Cited by 246
Folate receptor overexpression is associated with poor outcome in breast cancer
Hartmann, L. C., Keeney, G. L., Lingle, W. L., Christianson, T. J. H., Varghese, B., Hillman, D., Oberg, A. L., & Low, P. S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22811 · Cited by 245
Price, D. J., Miralem, T., Jiang, S., Steinberg, R., & Avraham, H. K. (2001) · PubMed · Cited by 243
Nishiyama, A., Lin, X.-H., Giese, N., Heldin, C.-H., & Stallcup, W. B. (1996) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19960201)43:3<315::aid-jnr6>3.0.co;2-m · Cited by 240
Vauquelin, G., & Charlton, S. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12106 · Cited by 231
Schlingemann, R. O., Rietveld, F. J. R., de Waal, R. M. W., Ferrone, S., & Ruiter, D. J. (1990) · Europe PMC (PubMed Central) · Cited by 224
What distinguishes tenascin from fibronectin?
Chiquet‐Ehrismann, R. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.9.1693347 · Cited by 219
Cell-penetrating Peptides as Versatile Vehicles for Oligonucleotide Delivery
Margus, H., Padari, K., & Pooga, M. (2012) · Molecular Therapy · doi:10.1038/mt.2011.284 · Cited by 214
A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth
Yan, X. (2003) · Blood · doi:10.1182/blood-2002-04-1004 · Cited by 214
Henderson, G. B. (1990) · Annual Review of Nutrition · doi:10.1146/annurev.nu.10.070190.001535 · Cited by 214
Selection of Tumor-binding Ligands in Cancer Patients with Phage Display Libraries
Krag, D. N., Shukla, G. S., Shen, G.-P., Pero, S., Ashikaga, T., Fuller, S., Weaver, D. L., Burdette-Radoux, S., & Thomas, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4441 · Cited by 212
Lindgren, M., Rosenthal-Aizman, K., Saar, K., Eiríksdóttir, E., Jiang, Y., Sassian, M., Östlund, P., Hällbrink, M., & Langel, Ü. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.048 · Cited by 207
Essler, M., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251687998 · Cited by 193
Tumor-Associated Macrophages Contribute to Tumor Progression in Ovarian Cancer
Colvin, E. K. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00137 · Cited by 192
High-affinity urokinase receptor antagonists identified with bacteriophage peptide display.
Goodson, R. J., Doyle, M. V., Kaufman, S. E., & Rosenberg, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7129 · Cited by 190
Tumour-initiating cells vs. cancer ‘stem’ cells and CD133: What’s in the name?
Neuzil, J., Stantic, M., Zobalova, R., Chladova, J., Wang, X., Prochazka, L., Dong, L., Andera, L., & Ralph, S. J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.159 · Cited by 189
The RGD story: a personal account
Ruoslahti, E. (2003) · Matrix Biology · doi:10.1016/s0945-053x(03)00083-0 · Cited by 189
Pericyte Dynamics during Angiogenesis: New Insights from New Identities
Stapor, P. C., Sweat, R. S., Dashti, D. C., Betancourt, A. M., & Murfee, W. L. (2014) · Journal of Vascular Research · doi:10.1159/000362276 · Cited by 188
Jung, W., Castren, E., Odenthal, M., Vande Woude, G. F., Ishii, T., Dienes, H. P., Lindholm, D., & Schirmacher, P. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.2.485 · Cited by 183
Ghosh, S., Sullivan, C. A. W., Zerkowski, M. P., Molinaro, A. M., Rimm, D. L., Camp, R. L., & Chung, G. G. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.06.004 · Cited by 182
Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo
Song, S., Liu, D., Peng, J., Sun, Y., Li, Z., Gu, J.-R., & Xu, Y. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.012 · Cited by 180
Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery
Lo, A., Lin, C.-T., & Wu, H.-C. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2359 · Cited by 179
Bae, Y. K., Kim, A., Kim, M. K., Choi, J. E., Kang, S. H., & Lee, S. J. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.03.006 · Cited by 171
Cell-specific delivery of genes with glycosylated carriers
HASHIDA, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00209-5 · Cited by 171
A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system
Zhang, Q., Tang, J., Fu, L., Ran, R., Liu, Y., Yuan, M., & He, Q. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.014 · Cited by 170
The multiple roles of tumour stroma
Wernert, N. (1997) · Virchows Archiv · doi:10.1007/s004280050053 · Cited by 170
Combined Effects of Pericytes in the Tumor Microenvironment
Ribeiro, A. L., & Okamoto, O. K. (2015) · Stem Cells International · doi:10.1155/2015/868475 · Cited by 168
Macrophage-Specific RNA Interference Targeting via “Click”, Mannosylated Polymeric Micelles
Yu, S. S., Lau, C. M., Barham, W. J., Onishko, H. M., Nelson, C. E., Li, H., Smith, C. A., Yull, F. E., Duvall, C. L., & Giorgio, T. D. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300434e · Cited by 166
NG2 proteoglycan-binding peptides target tumor neovasculature.
Burg, M. A., Pasqualini, R., Arap, W., Ruoslahti, E. I., & Stallcup, W. B. (1999) · PubMed · Cited by 166
Kajita, T., Ohta, Y., Kimura, K., Tamura, M., Tanaka, Y., Tsunezuka, Y., Oda, M., Sasaki, T., & Watanabe, G. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1882 · Cited by 164
Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy
Li, C., Zhang, N., Zhou, J., Ding, C., Jin, Y., Cui, X., Pu, K., & Zhu, Y. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0035 · Cited by 161
Koukourakis, M. I., Giatromanolaki, A. N., Thorpe, P. E., Brekken, R. A., Sivridis, E., Kakolyris, S., Georgoulias, V., Gatter, K. C., & Harris, A. L. (2000) · PubMed · Cited by 159
CD146 acts as a novel receptor for netrin-1 in promoting angiogenesis and vascular development
Tu, T., Zhang, C., Yan, H., Luo, Y., Kong, R., Wen, P., Ye, Z., Chen, J., Feng, J., Liu, F., et al. (2015) · Cell Research · doi:10.1038/cr.2015.15 · Cited by 158
Vascular zip codes in angiogenesis and metastasis
Ruoslahti, E. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320397 · Cited by 158
Targeting tumor vasculature with homing peptides from phage display
Ruoslahti, E. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0334 · Cited by 157
Song, S., Liu, D., Peng, J., Deng, H., Guo, Y., Xu, L. X., Miller, A. D., & Xu, Y. (2009) · The FASEB Journal · doi:10.1096/fj.08-117002 · Cited by 157
Peptide-Mediated Targeting to Tumor Blood Vessels of Lung Cancer for Drug Delivery
Lee, T.-Y., Lin, C., Kuo, S.-Y., Chang, D.-K., & Wu, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2233 · Cited by 156
The α folate receptor is highly activated in malignant pleural mesothelioma
Bueno, R., Appasani, K., Mercer, H., et al. (2001) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.111176 · Cited by 155
Targeting Signal Transducer and Activator of Transcription Signaling Pathway in Leukemias
Beneklı, M., Baumann, H., & Wetzler, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.3264 · Cited by 152
Kumar, R., Mandal, M., Lipton, A., Harvey, H. A., & Thompson, C. B. (1996) · PubMed · Cited by 144
Chang, D.-K., Lin, C., Wu, C., & Wu, H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004171 · Cited by 137
Role of erbB2 in breast cancer chemosensitivity
Yu, D., & Hung, M. (2000) · BioEssays · doi:10.1002/1521-1878(200007)22:7<673::aid-bies10>3.0.co;2-a · Cited by 130
Cloning and expression of the tumor-associated antigen L6.
Marken, J. S., Schieven, G. L., Hellström, I., Hellström, K. E., & Aruffo, A. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3503 · Cited by 129
Monoclonal mouse antibodies raised against human lung carcinoma
Hellstrom, I., Horn, D., Linsley, P. S., Brown, J., Brankovan, V., & Hellström, K. E. (1987) · Lung Cancer · doi:10.1016/s0169-5002(87)80426-9 · Cited by 129
Prostate epithelial stem cells
Rizzo, S., Attard, G., & Hudson, D. L. (2005) · Cell Proliferation · doi:10.1111/j.1365-2184.2005.00356.x · Cited by 121
Involvement of Large Tenascin-C Splice Variants in Breast Cancer Progression
Tsunoda, T., Inada, H., Kalembeyi, I., Imanaka‐Yoshida, K., Sakakibara, M., Okada, R., Katsuta, K., Sakakura, T., Majima, Y., & Yoshida, T. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64320-9 · Cited by 120
Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146
Ouhtit, A., Gaur, R. L., Elmageed, Z. Y. A., Fernando, A., Thouta, R., Trappey, A., Abdraboh, M. E., El‐Sayyad, H. I., Rao, P. N., & Raj, M. H. G. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.01.002 · Cited by 119
Hanamura, N., Yoshida, T., Matsumoto, E., Kawarada, Y., & Sakakura, T. (1997) · International Journal of Cancer · Cited by 118
Chang, S. S., Reuter, V. E., Heston, W. D. W., & Gaudin, P. B. (2001) · Urology · doi:10.1016/s0090-4295(01)00983-9 · Cited by 116
Prostate cancer relevant antigens and enzymes for targeted drug delivery
Barve, A. J., Jin, W., & Cheng, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.035 · Cited by 115
Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease
Wang, J., Masehi-Lano, J. J., & Chung, E. J. (2017) · Biomaterials Science · doi:10.1039/c7bm00271h · Cited by 110
Naidoo, J., Page, D. B., & Wolchok, J. D. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2014.02.002 · Cited by 108
Wnt5a uses CD146 as a receptor to regulate cell motility and convergent extension
Ye, Z., Zhang, C., Tu, T., Sun, M., Liu, D., Lü, D., Feng, J., Yang, D., Liu, F., & Yan, X. (2013) · Nature Communications · doi:10.1038/ncomms3803 · Cited by 102
Harhouri, K., Kebir, A., Guillet, B. A., Foucault‐Bertaud, A., Voytenko, S., Piercecchi‐Marti, M., Berenguer‐Daizé, C., Lamy, E., Vely, F., Pisano, P. S., et al. (2010) · Blood · doi:10.1182/blood-2009-06-229591 · Cited by 102
Phthalocyanine–Peptide Conjugates for Epidermal Growth Factor Receptor Targeting
Ongarora, B. G., Fontenot, K. R., Hu, X., Sehgal, I., Satyanarayanajois, S. D., & Vicente, M. G. H. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201544y · Cited by 100
Folate receptor allows cells to grow in low concentrations of 5-methyltetrahydrofolate.
Matsue, H., Rothberg, K. G., Takashima, A., Kamen, B. A., Anderson, R. G. W., & Lacey, S. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.6006 · Cited by 99
Amaya, H., Tanigawa, N., Lu, C., Matsumura, M., Shimomatsuya, T., Horiuchi, T., & Muraoka, R. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00280-2 · Cited by 99
Klein, G., Beck, S. C., & Müller, C. A. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.123.4.1027 · Cited by 92
Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas.
Hellström, I., Beaumier, P. L., & Hellström, K. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.18.7059 · Cited by 91
EDB Fibronectin Specific Peptide for Prostate Cancer Targeting
Han, Z., Zhou, Z., Shi, X., Wang, J., Wu, X., Sun, D., Chen, Y., Zhu, H., Magi‐Galluzzi, C., & Lu, Z. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00178 · Cited by 90
The L6 Protein TM4SF1 Is Critical for Endothelial Cell Function and Tumor Angiogenesis
Shih, S., Zukauskas, A., Li, D., Liu, G., Ang, L., Nagy, J. A., Brown, L. F., & Dvorak, H. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4886 · Cited by 89
Su, J.-L., Lai, K.-P., Chen, C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0188 · Cited by 89
Knockdown of CD146 reduces the migration and proliferation of human endothelial cells
Kang, Y., Wang, F., Feng, J., Yang, D., Yang, X., & Yan, X. (2006) · Cell Research · doi:10.1038/sj.cr.7310039 · Cited by 87
Kebir, A., Harhouri, K., Guillet, B. A., Liu, J. W., Foucault‐Bertaud, A., Lamy, E., Kaspi, É., Elganfoud, N., Vely, F., Sabatier, F., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.213827 · Cited by 85
Aldeghaither, D. S., Smaglo, B. G., & Weiner, L. M. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.407 · Cited by 79
Effect of PEG Pairing on the Efficiency of Cancer-Targeting Liposomes
Saw, P. E., Park, J., Lee, E., Ahn, S., Lee, J., Kim, H., Kim, J., Choi, M., Farokhzad, O. C., & Jon, S. (2015) · Theranostics · doi:10.7150/thno.10732 · Cited by 77
Self-citationZheng, C., Qiu, Y., Zeng, Q., Zhang, Y., Lü, D., Yang, D., Feng, J., & Yan, X. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.03.014 · Cited by 76
Synergistic Interactions between Tamoxifen and Trastuzumab (Herceptin)
Argiris, A. E., Wang, C.-X., Whalen, S. G., & DiGiovanna, M. P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1060-02 · Cited by 73
Critical roles of CD146 in zebrafish vascular development
Chan, B., Sinha, S., Cho, D., Ramchandran, R., & Sukhatme, V. P. (2004) · Developmental Dynamics · doi:10.1002/dvdy.20220 · Cited by 71
Ai, S., Duan, J., Liu, X., Bock, S., Tian, Y., & Huang, Z. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100243j · Cited by 69
Kim, S., Kim, D., Jung, H.-H., Lee, I.-H., Kim, J., Suh, J., & Jon, S. (2012) · Angewandte Chemie · doi:10.1002/anie.201107894 · Cited by 68
Peptide-Based Selective Inhibitors of Matrix Metalloproteinase-Mediated Activities
Ndinguri, M. W., Bhowmick, M., Tokmina‐Roszyk, D., Robichaud, T. K., & Fields, G. B. (2012) · Molecules · doi:10.3390/molecules171214230 · Cited by 68
Natural Peptides with Potential Applications in Drug Development, Diagnosis, and/or Biotechnology
Hayashi, M. A. F., Ducancel, F., & Konno, K. (2012) · International Journal of Peptides · doi:10.1155/2012/757838 · Cited by 68
Inufusa, H., Nakamura, M., Adachi, T., Nakatani, Y., Shindo, K., Yasutomi, M., & Matsuura, H. (1995) · Cancer · doi:10.1002/1097-0142(19950615)75:12<2802::aid-cncr2820751204>3.0.co;2-o · Cited by 67
Aptide-conjugated liposome targeting tumor-associated fibronectin for glioma therapy
Saw, P. E., Kim, S., Lee, I., Park, J., Yu, M., Lee, J., Kim, J., & Jon, S. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20815j · Cited by 63
Self-citationHindermann, W., Berndt, A., Borsi, L., Luo, X., Hyckel, P., Katenkamp, D., & Kosmehl, H. (1999) · The Journal of Pathology · Cited by 59
A novel mouse CD133 binding-peptide screened by phage display inhibits cancer cell motility in vitro
Sun, J., Zhang, C., Liu, G., Liu, H., Zhou, C.-P., Lu, Y., Zhou, C., Li, Y., & Li, X. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9440-6 · Cited by 58
Selection and Characterization of Tenascin C Targeting Peptide
Kim, M. Y., Kim, O. R., Choi, Y. S., Lee, H., Park, K., Lee, C., Kang, K. W., & Jeong-Yu, S. (2011) · Molecules and Cells · doi:10.1007/s10059-012-2214-4 · Cited by 58
Discovery of PSMA-specific peptide ligands for targeted drug delivery
Jin, W., Qin, B. Y., Chen, Z., Liu, H., Barve, A. J., & Cheng, K. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.08.048 · Cited by 55
Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging
Park, J., Kim, S., Saw, P. E., Lee, I.-H., Yu, M. K., Kim, M., Lee, K., Kim, Y.-C., Jeong, Y. Y., & Jon, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.08.029 · Cited by 48
Self-citationXing, L., Xu, Y., Sun, K., Wang, H., Zhang, F., Zhou, Z., Zhang, J., Zhang, F., Caliskan, B., Qiu, Z., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26683-z · Cited by 48
Trastuzumab Plus Tamoxifen: Anti-Proliferative and Molecular Interactions in Breast Carcinoma
Ropero, S., Menéndez, J. A., Vázquez‐Martín, A., Montero, S., Cortés-Funes, H., & Colomer, R. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000032981.20384.c6 · Cited by 47
Increasing Solubility of Proteins and Peptides by Site-Specific Modification with Betaine
Xiao, J., Burn, A., & Tolbert, T. J. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800063k · Cited by 47
Novel Anti-TM4SF1 Antibody–Drug Conjugates with Activity against Tumor Cells and Tumor Vasculature
Visintin, A., Knowlton, K. M., Tyminski, E., Lin, C., Zheng, X., Marquette, K., Jain, S., Tchistiakova, L., Li, D., O’Donnell, C. J., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0188 · Cited by 45
Brinton, L. T., Bauknight, D. K., Dasa, S. S. K., & Kelly, K. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155244 · Cited by 45
Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ
Wülfing, P., Kersting, C., Buerger, H., Mattsson, B., Mesters, R. M., Gustmann, C., Hinrichs, B., Tio, J., Böcker, W., & Kiesel, L. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602567 · Cited by 43
Yang, H., Liu, S., Cai, H., Wan, L., Li, S., Li, Y., Cheng, J., & Lu, X. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.089417 · Cited by 43
Anti-Endosialin Antibody–Drug Conjugate: Potential in Sarcoma and Other Malignancies
Rouleau, C., Gianolio, D. A., Smale, R., Roth, S. D., Krumbholz, R. D., Harper, J. W., Munroe, K. J., Green, T. L., HORTEN, B. C., Schmid, S. M., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0312 · Cited by 43
Li, J., Wang, H., Li, J., Bao, J., & Wu, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071055 · Cited by 43
Cited by
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02107-5 · Cited by 449
Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy
Li, J., Wang, Q., Xia, G., Adilijiang, N., Li, Y., Hou, Z., Fan, Z., & Li, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092233 · Cited by 278
Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapy
Lin, Y., Yan, M., Bai, Z., Xie, Y., Ren, L., Wei, J., Zhu, D., Wang, H., Liu, Y., Luo, J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01636-x · Cited by 125
“Phage display has been used for performing high-throughput screening and identifying functional peptide ligands for various targets, including PD-L1 [28], tumor stromal cells [29], and ischemic myocardial tissues [30].”
MethodPeptides for Vaccine Development
Hamley, I. W. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c01238 · Cited by 104
Bacteriophages as Solid Tumor Theragnostic Agents
Veeranarayanan, S., Azam, A. H., Kiga, K., Watanabe, S., & Cui, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010402 · Cited by 39
Metadata
- Authors
- Saw, P. E., & Song, E.-W.
- Venue
- Protein & Cell
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-05-28
- Volume
- 10
- Issue
- 11
- Pages
- 787-807
- ISSN
- 1674-800X (ISSN-L)
- 1674-8018
- OpenAlex
- W2947027538
- Cited by
- 279
- References
- 217
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.